Sofinnova Investments, Inc. Axsome Therapeutics, Inc. Put Options Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	BUY	$78.93 - $95.84 $11.8 Million - $14.4 Million	150,000 New	150,000 $13.5 Million
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $2.37 Million - $4.14 Million	-100,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $3.07 Million - $4.34 Million	100,000 New	100,000 $3.78 Million

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.